Topic Hub
7 educational articles in the WomenRx archive. This archive is being reviewed before search indexing.
Explore
Showing 7 of 7 clinical reviews.
Retatrutide is Eli Lilly's triple-hormone GLP-1/GIP/glucagon agonist showing 24% weight loss in trials. Here's how its projected cost stacks up against semaglutide, tirzepatide, and other alternatives for women.
Read clinical reviewHow renal impairment affects retatrutide dosing for women, including life-stage differences, pregnancy safety, and what the Phase 2 trial data actually shows.
Read clinical reviewHow retatrutide works in women with transplants, HIV, PCOS, and other complex conditions. Sex-specific dosing, drug interactions, and pregnancy safety explained.
Read clinical reviewMissed a retatrutide injection? This women's-health guide covers exactly when to take it, when to skip it, and how hormones and life stage change your risk.
Read clinical reviewRetatrutide is still under patent. Here's when generics may arrive, how the drug works, and what every woman should know about safety by life stage.
Read clinical reviewHow retatrutide is absorbed, distributed, metabolized, and excreted, with women-specific dosing, hormonal interactions, and pregnancy safety data explained.
Read clinical reviewHow to store retatrutide correctly, what affects its stability, and shelf-life data from Phase 2 trials. Women-specific guidance included.
Read clinical review